Civica Rx Welcomes New Founding Members as 12 Additional Health Systems Join Forces to Reduce Chronic Drug Shortages

January 7, 2019 |

2 min read

Civica Rx has announced that 12 health systems, representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members.

SALT LAKE CITY--(BUSINESS WIRE)-- Civica Rx has announced that 12 health systems, representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members. When combined with hospitals represented by the initial governing members of Civica Rx, approximately 750 U.S. hospitals have joined the mission-driven venture so far, with many more health systems expressing interest.

Civica Rx was established in 2018 by three philanthropies and seven leading health systems that experience first-hand the impact of drug shortages, which have become all too common and affect all aspects of the health care delivery system. The highly-collaborative initiative will result in lower costs and more predictable supplies of many medicines, helping ensure that patients and their needs come first in the generic drug marketplace.

Civica Rx members drive drug selection decisions to ensure Civica Rx manufactures the medications that are most essential to patient care. The 12 new founding members include:

Advocate Aurora Health
Allegheny Health Network
Baptist Health South Florida
Franciscan Alliance
Memorial Hermann Health System
NYU Langone Health
Ochsner Health System
Sanford Health
Spectrum Health
St. Luke’s University Health Network
Steward Health Care
UnityPoint Health

“We are thrilled to welcome these highly-regarded health systems to Civica as founding members,” said Martin VanTrieste, CEO of Civica Rx. “Drug shortages have become a national crisis where patient treatments and surgeries are canceled, delayed or suboptimal. We thank these organizations for joining us to make essential generic medicines accessible and affordable in hospitals across the country.”

Civica Rx expects to bring over 14 hospital-administered generic drugs to hospitals and health care systems in 2019 as the initial focus of the company’s efforts, with many additional medications prioritized by the healthcare systems as the next phase of focus. The company is working towards becoming an FDA approved manufacturer and will either directly manufacture generic drugs or sub-contract manufacturing to trusted supply partners.

These founding members join the previously announced governing members of Civica Rx, which include Catholic Health Initiatives, the Gary and Mary West Foundation, HCA Healthcare, Intermountain Healthcare, Laura & John Arnold Foundation, Mayo Clinic, the Peterson Center on Healthcare, Providence St. Joseph Health, SSM Health, and Trinity Health. Civica Rx is collaborating with the American Hospital Association’s (AHA) newly formed AHA Center for Health Innovation to address inquiries about the initiative. Health systems and hospitals may call 800-242-4677 with questions, or visit www.civicarx.org for information.